Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2015, Article ID 183094, 5 pages
http://dx.doi.org/10.1155/2015/183094
Research Article

Comparison of Glomerular Filtration Rate Estimation from Serum Creatinine and Cystatin C in HNF1A-MODY and Other Types of Diabetes

1Department of Metabolic Diseases, Jagiellonian University Medical College, 15 Kopernika Street, 31-501 Krakow, Poland
2University Hospital, Krakow, Poland
3Department of Diagnostics, Jagiellonian University Medical College, Krakow, Poland
4Department of Clinical Genetics, Medical University of Lodz, Lodz, Poland

Received 29 June 2015; Revised 24 July 2015; Accepted 28 July 2015

Academic Editor: Bernard Portha

Copyright © 2015 Magdalena Szopa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. T. Valmadrid, R. Klein, S. E. Moss, and B. E. Klein, “The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus,” Archives of Internal Medicine, vol. 160, no. 8, pp. 1093–1100, 2000. View at Publisher · View at Google Scholar
  2. I. H. de Boer, R. Katz, J. J. Cao et al., “Cystatin C, albuminuria, and mortality among older adults with diabetes,” Diabetes Care, vol. 32, no. 10, pp. 1833–1838, 2009. View at Publisher · View at Google Scholar
  3. G. S. Collins, O. Omar, M. Shanyinde, and L. M. Yu, “A systematic review finds prediction models for chronic kidney disease were poorly reported and often developed using inappropriate methods,” Journal of Clinical Epidemiology, vol. 66, no. 3, pp. 268–277, 2013. View at Publisher · View at Google Scholar
  4. T. I. Chang, S. Li, S. C. Chen et al., “Risk factors for ESRD in individuals with preserved estimated GFR with and without albuminuria: results from the Kidney Early Evaluation Program (KEEP),” American Journal of Kidney Diseases, vol. 61, no. 4, supplement 2, pp. S4–S11, 2013. View at Publisher · View at Google Scholar
  5. T. Ninomiya, V. Perkovic, B. E. de Galan et al., “Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes,” Journal of the American Society of Nephrology, vol. 20, no. 8, pp. 1813–1821, 2009. View at Publisher · View at Google Scholar
  6. A. S. Krolewski, M. A. Niewczas, J. Skupien et al., “Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria,” Diabetes Care, vol. 37, no. 1, pp. 226–234, 2013. View at Publisher · View at Google Scholar
  7. A. S. Levey, L. A. Stevens, C. H. Schmid et al., “A new equation to estimate glomerular filtration rate,” Annals of Internal Medicine, vol. 150, no. 9, pp. 604–612, 2009. View at Publisher · View at Google Scholar
  8. L. A. Inker, C. H. Schmid, H. Tighiouart et al., “Estimating glomerular filtration rate from serum creatinine and cystatin C,” The New England Journal of Medicine, vol. 367, no. 1, pp. 20–29, 2012. View at Publisher · View at Google Scholar
  9. L. A. Stevens, C. H. Schmid, T. Greene et al., “Factors other than glomerular filtration rate affect serum cystatin C levels,” Kidney International, vol. 75, no. 6, pp. 652–660, 2009. View at Publisher · View at Google Scholar
  10. N. Nowak, M. Szopa, G. Thanabalasingham et al., “Cystatin C is not a good candidate biomarker for HNF1A-MODY,” Acta Diabetologica, vol. 50, no. 5, pp. 815–820, 2013. View at Publisher · View at Google Scholar
  11. T. Klupa, I. Solecka, N. Nowak et al., “The influence of dietary carbohydrate content on glycaemia in patients with glucokinase maturity-onset diabetes of the young,” Journal of International Medical Research, vol. 39, no. 6, pp. 2296–2301, 2011. View at Publisher · View at Google Scholar
  12. J. Skupien, S. Gorczynska-Kosiorz, T. Klupa et al., “Molecular background and clinical characteristics of HNF1A MODY in a Polish population,” Diabetes & Metabolism, vol. 34, no. 5, pp. 524–528, 2008. View at Publisher · View at Google Scholar
  13. M. A. Ferguson and S. S. Waikar, “Established and emerging markers of kidney function,” Clinical Chemistry, vol. 58, no. 4, pp. 680–689, 2012. View at Publisher · View at Google Scholar
  14. M. G. Shlipak, K. Matsushita, J. Ärnlöv et al., “Cystatin C versus creatinine in determining risk based on kidney function,” The New England Journal of Medicine, vol. 369, no. 10, pp. 932–943, 2013. View at Publisher · View at Google Scholar
  15. C. Tsai, M. E. Grams, L. A. Inker, J. Coresh, and E. Selvin, “Cystatin C- and creatinine-based estimated glomerular filtration rate, vascular disease, and mortality in persons with diabetes in the U.S.,” Diabetes Care, vol. 37, no. 4, pp. 1002–1008, 2014. View at Publisher · View at Google Scholar
  16. B. Schöttker, C. Herder, H. Muller, H. Brenner, and D. Rothenbacher, “Clinical utility of creatinine- and cystatin C-based definition of renal function for risk prediction of primary cardiovascular events in patients with diabetes,” Diabetes Care, vol. 35, no. 4, pp. 879–886, 2012. View at Publisher · View at Google Scholar
  17. M. E. Grams, S. P. Juraschek, E. Selvin et al., “Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates,” American Journal of Kidney Diseases, vol. 62, no. 2, pp. 253–260, 2013. View at Publisher · View at Google Scholar
  18. D. Z. Cherney, E. B. Sochett, M. G. Dekker, and B. A. Perkins, “Ability of cystatin C to detect acute changes in glomerular filtration rate provoked by hyperglycaemia in uncomplicated Type 1 diabetes,” Diabetic Medicine, vol. 27, no. 12, pp. 1358–1365, 2010. View at Publisher · View at Google Scholar
  19. I. H. de Boer, W. Sun, P. A. Cleary et al., “Longitudinal changes in estimated and measured GFR in type 1 diabetes,” Journal of the American Society of Nephrology, vol. 25, no. 4, pp. 810–818, 2014. View at Publisher · View at Google Scholar
  20. F. Iliadis, T. Didangelos, A. Ntemka et al., “Glomerular filtration rate estimation in patients with type 2 diabetes: creatinine- or cystatin C-based equations?” Diabetologia, vol. 54, no. 12, pp. 2987–2994, 2011. View at Publisher · View at Google Scholar
  21. S. J. Oh, J. I. Lee, W. C. Ha et al., “Comparison of cystatin C- and creatinine-based estimation of glomerular filtration rate according to glycaemic status in Type 2 diabetes,” Diabetic Medicine, vol. 29, no. 7, pp. e121–e125, 2012. View at Publisher · View at Google Scholar
  22. K. Tanaka, S. Terryn, L. Geffers, S. Garbay, M. Pontoglio, and O. Devuyst, “The transcription factor HNF1α regulates expression of chloride-proton exchanger ClC-5 in the renal proximal tubule,” American Journal of Physiology: Renal Physiology, vol. 299, no. 6, pp. F1339–F1347, 2010. View at Publisher · View at Google Scholar
  23. S. Hara, K. Umeyama, T. Yokoo, H. Nagashima, and M. Nagata, “Diffuse glomerular nodular lesions in diabetic pigs carrying a dominant-negative mutant hepatocyte nuclear factor 1-alpha, an inheritant diabetic gene in humans,” PLoS ONE, vol. 9, no. 3, Article ID e92219, 2014. View at Publisher · View at Google Scholar
  24. M. Pontoglio, D. Prié, C. Cheret et al., “HNF1α controls renal glucose reabsorption in mouse and man,” EMBO Reports, vol. 1, no. 4, pp. 359–365, 2000. View at Publisher · View at Google Scholar